Index · 1 ranked
Funds Tracking the S&P Pharmaceuticals Select Industry
Ranked by expense ratio, lowest first.
Data as of May 31, 2026 ·How this data is built
As of May 31, 2026, FundVersus ranks 1 funds tracking the S&P Pharmaceuticals Select Industry by expense ratio. The lowest is State Street SPDR S&P Pharmaceuticals ETF (XPH) at 0.35%. The median is 0.35%; weighted by assets, 0.35%.
Facts from SEC filings. Not investment advice.
The ranking
Only the stated measure sets the order. Expense ratios from prospectuses; net assets and returns from Form N-PORT.
| # | Fund | Expense ratio | Net assets | 1-year return | |
|---|---|---|---|---|---|
| 1 | State Street SPDR S&P Pharmaceuticals ETFXPH · ETF · Health Care | 0.35% | $308M | +24.05% |
Questions
How is this list ranked?
Ranked by expense ratio, lowest first. It includes funds tracking the S&P Pharmaceuticals Select Industry with a current SEC filing and enough data for a FundVersus page. The ranking uses one stated measure and is not a recommendation.
Which has the lowest expense ratio?
State Street SPDR S&P Pharmaceuticals ETF (XPH), at 0.35% as of May 31, 2026.
How much money is in these funds?
The 1 funds on this list reported $308M in combined net assets on their latest filings.